Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

NCT: NCT05701917 · RECRUITING

NCT IDNCT05701917
StatusRECRUITING
Start Date2023-01-06
Completion2027-01-15

Brief Summary

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.

Frequently Asked Questions

What is DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis?

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis is a clinical trial registered under NCT05701917. Current status: RECRUITING.

What is the status of NCT05701917?

The current status of NCT05701917 (DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis) is: RECRUITING.

When did DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis start?

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis started on 2023-01-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.